Next Generation Sequencing Testing (NGS)

A Prior Information Notice
by NHS BLOOD AND TRANSPLANT

Source
Find a Tender
Type
Contract (Services)
Duration
1 year
Value
£0-£300K
Sector
TECHNOLOGY
Published
15 May 2025
Delivery
01 Oct 2025 to 30 Sep 2026
Deadline
n/a

Related Terms

Location

Bristol:

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.

CPV Codes

  • 72225000 - System quality assurance assessment and review services

Indicators

  • Renewals are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-0514f8
  • FTS 021932-2025

Domains